lymphoma: the 2016 who classification...2019/10/01 · september 27, 2019 disclosures • i have...
TRANSCRIPT
![Page 1: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/1.jpg)
What’s New in Cutaneous Lymphoma: the 2016 WHO
Classification
Uma Sundram, MD, PhDProfessor of Pathology
Oakland University William Beaumont School of Medicine
Beaumont Health Systems, Royal Oak, MISeptember 27, 2019
![Page 2: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/2.jpg)
Disclosures
• I have nothing relevant to disclose.
10/1/2019 2
![Page 3: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/3.jpg)
The 2016 WHO classification of lymphomas: What’s old (Swerdlow 2016; Sundram, 2019)
• Mycosis fungoides/Sézary syndrome• CD30+ lymphoproliferative disorders
(lymphomatoid papulosis, primary cutaneous ALCL)– C-ALCL and Lyp with chromosomal rearrangement
of 6p25.3
• Subcutaneous panniculitis like TCL
![Page 4: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/4.jpg)
The 2016 WHO classification of lymphomas: What is no longer provisional
• Hydroa vacciniforme like lymphoproliferative disorders (no longer strictly a lymphoma)
• Gamma delta TCL (no longer provisional)
![Page 5: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/5.jpg)
The 2016 WHO classification of lymphomas: What’s provisional
• Primary cutaneous CD8+ aggressive epidermotropic cytotoxic TCL
• Primary cutaneous CD4+ small medium pleomorphic T cell lymphoproliferative disorder (LPD)
• EBV positive mucocutaneous ulcer• Primary cutaneous acral CD8+ TCL• Breast implant associated ALCL
![Page 6: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/6.jpg)
Outline
• Discussion of some new entities– Hydroa vacciniforme like lymphoproliferative
disorder– Primary cutaneous ALCL with DUSP22-IRF4
rearrangement on 6p25.3– Breast implant associated ALCL– Primary cutaneous acral CD8+ T cell lymphoma
![Page 7: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/7.jpg)
Hydroa vacciniforme like LPD
• Nine year old Guatemalan boy with waxing and waning skin tumors and ulcers present for 3 years. The lesions start as arthropod like vesicles and subsequently form bullae.
![Page 8: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/8.jpg)
![Page 9: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/9.jpg)
A B
C D
![Page 10: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/10.jpg)
B C
D F
A A B C
D E F
CD3 CD30 CD56
EBV CD5 CD8
![Page 11: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/11.jpg)
Hydroa vacciniforme like lymphoproliferative disorder (LPD)• Chronic EBV+ LPD of childhood with risk of
progressing to lymphoma (Doeden, 2008) • Spectrum including classic HV at one end and
HV-like lymphoma at the other • Classic HV=rare, UV related vesiculopapular
eruption with scarring
![Page 12: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/12.jpg)
Hydroa vacciniforme like lymphoproliferative disorder (LPD)• HV-like lymphoma=HV like lesions but clonal
proliferation of T cells• Inability to demonstrate which patients will
only have HV and which will develop overt lymphoma=current terminology introduced into 2016 WHO classification (Gru, 2016)
![Page 13: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/13.jpg)
Hydroa vacciniforme like lymphoproliferative disorder (LPD)• Asian and South Americans more at risk for
developing lymphoma• Most cases seen in children • Classic HV can have marked facial edema and
lesions can be chronic• Systemic symptoms can occur in the HV-like
lymphoma end of the spectrum
![Page 14: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/14.jpg)
Hydroa vacciniforme like lymphoproliferative disorder (LPD)• The cells are medium sized, hyperchromatic,
and centered on the dermis• Epidermal necrosis and vesicles can be seen• Some overlap with the lesions of NK-T cell
lymphoma, with angiocentricity• Can express T or NK cell markers (or both)• Can be of αβ or γδ origin• EBV+
![Page 15: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/15.jpg)
Hydroa vacciniforme like lymphoproliferative disorder (LPD)• Differential diagnosis (on morphologic
grounds)– Aggressive NK leukemia (blood involvement by
atypical CD56+ cells would be present; skin involvement would be rare)
– Extranodal NK/T cell lymphoma (usually in adults, very aggressive clinical course with death measured in months)
![Page 16: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/16.jpg)
Hydroa vacciniforme like lymphoproliferative disorder (LPD)• Differential diagnosis (on morphologic
grounds)– Subcutaneous panniculitis like T cell lymphoma:
This lymphoma is based in the fat (panniculus) and its neoplastic cells show rimming of adipocytes
– The neoplastic cells express CD8 and are EBV and CD56 negative
– Dermal involvement is not usually present
![Page 17: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/17.jpg)
Hydroa vacciniforme like lymphoproliferative disorder (LPD)• Differential diagnosis (on morphologic
grounds)– Gamma delta T cell lymphoma: This lymphoma
has significant epidermal, dermal and subcutaneous involvement
– It can lack expression of CD4 and CD8; occasionally it is CD8+
– CD56 is positive but EBV is negative
![Page 18: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/18.jpg)
Hydroa vacciniforme like lymphoproliferative disorder (LPD)• Take home pearls = Patients are almost
always from Central or South America, or Japan/Korea/China
• Pediatric patients• Morphology/Immunohistochemistry/Mole-
cular=Huge overlap with other NK/T cell entities
• Really a clinical diagnosis!
![Page 19: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/19.jpg)
Bond Falls, near Paulding and Ontonagan, MI
![Page 20: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/20.jpg)
Primary cutaneous anaplastic large cell lymphoma with DUSP22-IRF4 rearrangement
• 55 year old man with a solitary 1.5 cm lesion on his lower left eyelid.
![Page 21: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/21.jpg)
![Page 22: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/22.jpg)
![Page 23: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/23.jpg)
![Page 24: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/24.jpg)
CD3
![Page 25: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/25.jpg)
CD4
![Page 26: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/26.jpg)
CD8
![Page 27: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/27.jpg)
CD5
![Page 28: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/28.jpg)
CD30
![Page 29: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/29.jpg)
Primary cutaneous anaplastic large cell lymphoma with DUSP22-IRF4 rearrangement
• Histology is of a dense dermal atypical lymphoid infiltrate
• Extensive epidermotropism is appreciated, but the lesion is a solitary papule (not characteristic of mycosis fungoides)
• Cells within the dermis are small to medium sized with hyperchromatic, hyperconvoluted nuclei
![Page 30: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/30.jpg)
Primary cutaneous anaplastic large cell lymphoma with DUSP22-IRF4 rearrangement
• Lesional cells are strongly CD30+ and CD3+, but lack CD4 and CD8 in the epidermotropic component
• The lesional cells retain CD2 and CD5 in the intraepidermal component
• A call to the clinician confirmed solitary, relatively large nature of the lesion and its rapid onset
![Page 31: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/31.jpg)
Primary cutaneous anaplastic large cell lymphoma with DUSP22-IRF4 rearrangement
• Given unusual histology and immunohistochemistry, we performed DUSP22-IRF4 rearrangement testing with break apart FISH probe (6p25.3)
• A rearrangement was present• After over a year of follow up, the patient is
alive and free of disease following excision of the primary lesion
![Page 32: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/32.jpg)
CD30+ Lymphoproliferative Disorders
• CD30+ lymphoproliferative disorders traditionally constitute four entities
• Primary cutaneous ALCL• Lymphomatoid papulosis• Transformed mycosis fungoides• Systemic ALCL with secondary cutaneous
involvement
![Page 33: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/33.jpg)
CD30+ Lymphoproliferative Disorders
• Significant overlap between pcALCL and lymphomatoid papulosis (Lyp)
• Lyp = waxing and waning small papules that come in crops (groups of lesions) and fade over 2 week period
• pcALCL = larger (1.5 cm and above) lesion that does not fade over time, or fades very slowly (8 week period or more)
![Page 34: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/34.jpg)
![Page 35: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/35.jpg)
![Page 36: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/36.jpg)
CD30
![Page 37: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/37.jpg)
![Page 38: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/38.jpg)
![Page 39: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/39.jpg)
CD30
![Page 40: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/40.jpg)
Different types of Lyp
• None of these types change clinical outcome of Lyp at all!
• They are thought to be different time points of the same disease process
• Type A=wedge shaped dermal infiltrate with scattered CD30+ cells
• Type B = MF like with epidermotropism
![Page 41: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/41.jpg)
Different types of Lyp
• Type C= ALCL like, with dense dermal infiltrate of anaplastic cells
• Type D=similar in cytology to CD8+ cytotoxic lymphomas, with CD8 expression
• Type E=angioinvasive, most of these are CD8+
![Page 42: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/42.jpg)
pcALCL with DUSP22-IRF4 chromosomal rearrangements
• Recently chromosomal rearrangements have been described in both systemic and primary cutaneous ALCL (Pham-Ledard, 2010)
• In systemic ALCL, rearrangements of DUSP22and IRF4 at chromosome 6p25 leads to a relatively monomorphic tumor with lack of cytotoxic granules
• Superior prognosis
![Page 43: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/43.jpg)
pcALCL with DUSP22-IRF4 chromosomal rearrangements
• This translocation has been identified in pcALCL and lymphomatoid papulosis (Lyp)
• 20% of tested cases of pcALCL• Does not change prognosis or clinical outcome
(Kempf W, 2016)
![Page 44: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/44.jpg)
pcALCL with DUSP22-IRF4 chromosomal rearrangements
• Wada et al. observed that FISH for 6p25.3 rearrangement is highly specific for pcALCL in comparison to other cutaneous LPD (Wada, 2011)
• Only 1 of 32 (3%) of cases of Lyp had this translocation
![Page 45: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/45.jpg)
pcALCL with DUSP22-IRF4 chromosomal rearrangements
• pcALCL with this translocation often have a dense epidermotropic infiltrate of atypical cells
• Loss of CD4 and CD8 are documented• Cells within the dermis are composed
primarily of small to medium sized CD30+ cells, as opposed to ‘anaplastic’ cells often seen in ALCL
![Page 46: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/46.jpg)
pcALCL with DUSP22-IRF4 chromosomal rearrangements
• Take home pearl: Consider FISH if the lesion is a solitary cutaneous lesion that is CD30+ but has unusual histology for both ALCL and Lyp
• For now, no change in clinical management
![Page 47: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/47.jpg)
LELAND, MICHIGAN, ON LAKE MICHIGAN
![Page 48: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/48.jpg)
Breast Implant Associated ALCL
• 40 year old woman with history of saline implants, now with new left breast swelling
![Page 49: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/49.jpg)
![Page 50: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/50.jpg)
![Page 51: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/51.jpg)
CD3
![Page 52: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/52.jpg)
CD43
![Page 53: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/53.jpg)
CD30
![Page 54: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/54.jpg)
MUM1
![Page 55: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/55.jpg)
Breast Implant Associated ALCL
• Associated with patients with history of saline or silicone implants
• Localized breast swelling• Imaging shows mass, fluid collection adjacent
to implant, or both
![Page 56: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/56.jpg)
Breast Implant Associated ALCL
• Important-if lymphoma cells are confined to capsule or extend beyond capsule
• Lymph node involvement considered adverse finding
• ALCL-type hallmark cells found in aspirate or in capsule
• CD30+Alk-
![Page 57: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/57.jpg)
Breast Implant Associated ALCL
• Added as a provisional category to the 2016 WHO classification
• Rare and new• Outcomes different from both cutaneous and
systemic ALCL
![Page 58: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/58.jpg)
SPRING FLOWERS IN UPPER MICHIGAN
![Page 59: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/59.jpg)
Primary Cutaneous CD4+ Small/Medium T cell Lymphoproliferative Disorder
• 45 year old woman with solitary erythematous lesion on right cheek.
![Page 60: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/60.jpg)
![Page 61: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/61.jpg)
![Page 62: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/62.jpg)
![Page 63: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/63.jpg)
CD3
![Page 64: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/64.jpg)
CD20
![Page 65: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/65.jpg)
PD-1
![Page 66: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/66.jpg)
• Patients usually have a single or multiple plaques or tumors, without patches of MF
• Head and neck favored• Excellent prognosis, over 80% 5 year survival
(Beltraminelli 2009; Mattoch 2009; Maurelli 2017)
• Redesignated as a lymphoproliferative disorder in 2016 to reflect indolent course
Primary Cutaneous CD4+ Small/Medium T cell Lymphoproliferative Disorder
![Page 67: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/67.jpg)
Primary Cutaneous Small/Medium-sized CD4+ TCL• Dense diffuse skin infiltrates composed primarily of
small to medium sized T cells• Histologically heterogenous, unlike acral CD8+
lymphoma• A Grenz zone is usually present• Lymphocytes express CD3 and CD4, without loss of T
cell antigens
![Page 68: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/68.jpg)
Primary Cutaneous Small/Medium-sized CD4+ TCL• There can be a surprising number of B cells and/or
plasma cells (Rodriguez Pinilla 2009; Mattoch 2009; Magro 2019)
• Ki 67 rate is relatively low• PD-1 (marker of T follicular helper cells) is expressed• Some controversy in the literature whether these
represent a version of follicular T cell lymphoma
![Page 69: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/69.jpg)
SCOTT FALLS, NEAR AU TRAIN, MICHIGAN
![Page 70: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/70.jpg)
Primary cutaneous acral CD8+ lymphoma• 55 year old woman with erythematous lesions
on the ear and nose (case kindly shared by Dr Alistair Robson).
• Subsequently she developed small pinpoint erythematous lesions on the heel.
![Page 71: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/71.jpg)
![Page 72: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/72.jpg)
![Page 73: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/73.jpg)
![Page 74: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/74.jpg)
CD8
![Page 75: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/75.jpg)
![Page 76: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/76.jpg)
![Page 77: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/77.jpg)
Primary cutaneous acral CD8+ lymphoma• New provisional category in the 2016 WHO
classification of hematopoietic disorders• Initially described as lesions on the ear that
are indolent, have a Grenz zone, and express CD8 (Petrella, 2007)
• Several case series by Dr Robson and his colleagues further define this entity (Ally 2014)
![Page 78: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/78.jpg)
![Page 79: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/79.jpg)
Primary cutaneous acral CD8+ lymphoma• Erythematous papules and nodules on the ear,
nose, and acral sites (hands/feet) (Li 2014)• Solitary or multiple lesions• Can be rarely recurrent• While lesions on the ear were described first,
there is overlap with acral lesions
![Page 80: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/80.jpg)
Primary cutaneous acral CD8+ lymphoma• In the ear and on the nose = Grenz zone and
monomorphous population of cells with folded nuclei
• Interstitial growth pattern, perinuclear halos• Acral sites=Pautrier’s microabscesses• No folliculotropism or syringotropism
![Page 81: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/81.jpg)
Primary cutaneous acral CD8+ lymphoma• CD8+ cells with TIA-1 expression• EBV negative• Follicular T helper cell markers such as CXCL13
and PD-1 are negative• Ki67 can be low or high (up to 40%)
![Page 82: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/82.jpg)
Primary cutaneous acral CD8+ lymphoma• Clonal rearrangements• No systemic involvement• Long term follow up = recurrences can occur
but no other adverse events
![Page 83: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/83.jpg)
Primary cutaneous acral CD8+ lymphoma• NOT related to CD4+ small medium
pleomorphic T cell lymphoma• This latter lymphoma expresses PD1, ICOS and
CXCL13, unlike acral CD8+ lymphoma (Greenblatt 2013; Kluk 2016)
![Page 84: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/84.jpg)
Primary cutaneous acral CD8+ lymphoma• Take home pearl: Entity to consider if solitary,
small lesion on head and neck or acral site, with expression of CD8
![Page 85: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/85.jpg)
Summary
• Changes have been made to:– establish new provisional entities (EBV+
mucocutaneous ulcer)– designate aggressive entities as lymphomas
(gamma delta T cell lymphoma)– inject appropriate uncertainty into certain
categories (hydroa vacciniforme like LPD)– rename indolent entities (CD4+ small-medium T
cell LPD)
![Page 86: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/86.jpg)
Summary
• Expectations exist that in the future, new entities may be carved out of current ‘waste basket’ designations (PTCL-NOS)
• Molecular signature studies may further inform classification, treatment approaches, and understanding of clinical outcome
![Page 87: Lymphoma: the 2016 WHO Classification...2019/10/01 · September 27, 2019 Disclosures • I have nothing relevant to disclose. 10/1/2019 2 The 2016 WHO classification of lymphomas:](https://reader034.vdocuments.us/reader034/viewer/2022050122/5f52a23eaeebe17c693cf1b2/html5/thumbnails/87.jpg)
Isle Royale National Park, Isle Royale, MI